Brain/Kidney/Peripheral
Marijuana users have increased apoC3, triglycerides
May 19, 2008 | Lisa Nainggolan

Baltimore, MD - Heavy, chronic use of marijuana causes increased levels of apolipoprotein C3 (apoC3), which in turn results in a major increase in triglyceride levels, a small study shows [1]. The findings may explain some of the vascular effects of marijuana that have been observed, say Dr Subramaniam Jayanthi (National Institute on Drug Abuse, Baltimore, MD) and colleagues in their paper published online May 13, 2008 in Molecular Psychiatry.

Senior author Dr Jean Luc Cadet (National Institute on Drug Abuse) told heartwire: "A lot of people in cardiology have probably not been following the literature on marijuana, as most of it comes from the perspective of the neurologist or neuropsychiatrist. But in researching this topic, we came across a lot of papers suggesting that marijuana has acute cardiovascular effects, and we ourselves published a paper in 2005 showing that heavy marijuana users had increased resistance to brachial flow."

Cadet says the new finding of a substantial increase in apolipoprotein C3 in heavy marijuana users "requires confirmation," but it should prompt doctors to ask patients about marijuana use. Marijuana is the most commonly abused drug in the US, and "most cardiologists are not thinking of marijuana as a drug with major medical toxicity," he notes, "but there is evidence of cardiovascular side effects that might be related to the elevation in apolipoprotein C3 that we saw."


ApoC3: An agent in a complex network?
Most cardiologists are not thinking of marijuana as a drug with major medical toxicity.

In their paper, Jayanthi et al explain that the physiologic effects of marijuana are mediated via the active ingredient, tetrahydrocannabinol (THC), binding to cannabinoid receptors that are found in the brain and in the periphery, including in the heart, liver, kidney, spleen, small intestine, testes, and ovaries. Research has already shown that marijuana abuse causes increased resistance to blood flow and may increase the risk of certain cardiovascular disorders, they note.

Hence, they decided to test the possibility that marijuana use might be associated with changes in serum protein levels using a new proteomic approach. They examined 18 heavy marijuana users and 24 controls and found that the marijuana users had significant increases in three protein peaks, which were identified as three isoforms of a major lipoprotein, apoC3. The latter is a cardiovascular risk factor, and the present study "has now identified apolipoprotein C3 as a possible agent in the complex network of marijuana-induced effects in humans," they note.

They also found significant correlations between apoC3 and triglyceride levels. The mean triglyceride level in the 18 marijuana users was 122.0 mg/dL, compared with 91.17 mg/dL in the 24 controls. This is consistent with a previous paper—albeit 20 years old—that reported significant increases in HDL-triglyceride concentrations in marijuana users compared with controls, they note.

"The observed increases in apolipoprotein C3 in the marijuana users hint of the possibility that chronic marijuana abuse could lead to impairments of cellular energetics and mitochondrial function, which are critical events associated with myocardial infarction, stroke, and ischemic/reperfusion damage," they say.

In conclusion, Cadet stressed to heartwire that this is a small study, "and we'd like to see a larger group of people evaluated to see if this really holds. But in the meantime, doctors should ask patients about a history of drug abuse, and if they have been smoking marijuana, it may be worth checking triglyceride levels."

Source
  1. Jayanthi S, Buie S, Moore S, et al. Heavy marijuana users show increased serum apolipoprotein C3 levels: evidence from proteomic analyses.Mol Psychiatry 2008; DOI: 10.1038/mp.2008.50. Available at: www.nature.com/mp.



Your comments
Marijuana users have increased apoC3, triglycerides
# 1 of 4
May 19, 2008 05:54 PM (EDT)
Melissa Walton-Shirley
Another interesting piece of info
"The most commonly abused drug" in America is often not thought of as a drug at all, at least by those of us who are standing at the bedside trying to include or exclude risk factors for the presence of CAD.
One thought.....since TG's are increased with marijuana use, was there any discussion regarding relative glucose intolerance among marijuana users? Was there correction for BSA in this study ?
Tg's are a major hint at undetected diabetes and in this wierd world of genomic science, who really knows if an entity is the cause or the effect. Maybe with studies like these we will indeed find out which came first, the chicken or the egg.

Melissa
# 2 of 4
May 20, 2008 10:24 PM (EDT)
steven tatar
Inverse lipid changes?
Interesting Melissa.

Since rimonabant is legal (at least in Europe and prec;inically in USA), and therefore more studied, we know that cannabis receptor inhibition reduces triglicerides (and glucose and insulin levels while increasing HDL). It would be nice to know if apoC3 was also reduced.

Somewhat confusing is the finding in the cited 20 year old study in marijuana smokers that reported not just TG increase, but HDL as well, compared to a control group. Perhaps concomitant greater alcohol use in the marijuana smokers explains this association.

# 3 of 4
May 21, 2008 08:50 AM (EDT)
Melissa Walton-Shirley
HDL....just along for the ride?
I found the HDL effect intriguing as well, but we know the variations in the HDL story that have already played out in the last two years do not always spell protection.
Because of this study, I casually asked one of my former drug abusers if he uses any "drugs" now at all. "No, absolutely NOT".
What about marijuana?
"Well, yes, it helps me with my nausea, but I don't use any real drugs."
We still have a lot of education to do.
Melissa
# 4 of 4
May 29, 2008 01:01 AM (EDT)
David Kirk
Smoke as the vehicle for drug delivery
I know this off the topic somewhat, but with many nicotine users now avoiding smoking as a vehicle for drug delivery, isn't it time to start to differentiate between smoked Marijuana and the use (potential or already established) of other delivery systems?

Is the drug the problem (in both medicinal and recreational users) or is it the smoking?
And how does smoked Marijuana compare with ingested Marijuana in terms of biological markers?

You have to be logged in to add a comment to this article
Login
Username 
Password 
  Forgot your password?
 
Remember me on this computer
 
Register
Click on "register" to create a account - It is free....
 
button
Previews
Featured CME
Inside: Brain/Kidney/Peripheral
Brain/Kidney/Peripheral
Mar 27, 2008 11:13 EDT
Dr Alan Lumsden walks us through a lower limb percutaneous revascularization procedure, pointing out technical tips and common pitfalls along the way.